Insider · CIK 0001705745
Daniel Menold
Files at CBAY (CymaBay Therapeutics, Inc.). First filing Dec 15, 2023, latest Jan 16, 2024.
In brief
Daniel Menold files SEC Form 4 as officer at CBAY (CymaBay Therapeutics, Inc.). Since Dec 15, 2023, Daniel Menold has reported 0 open-market buys worth $0 and 2 open-market sells worth $708k, the latest filed on Jan 16, 2024.
A track record needs three past buys with six months of prices behind them; Daniel Menold has 0, so none is measured yet.
The newest scored trade: sold $236k of CBAY on Jan 16, 2024, filed Jan 16, 2024, scored 28 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | CymaBay Therapeutics, Inc. | $236k 10,000 shares | -100% | - | |
| 32Weak | CymaBay Therapeutics, Inc. | $473k 21,497 shares | -215% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 15, 2024 | CBAY CYMABAY THERAPEUTICS, INC. | 10,000 0.01% of outstanding | $322k | Feb 15, 2024 | $3.4M |
| Feb 1, 2024 | CBAY CymaBay Therapeutics, Inc. | 25,000 0.02% of outstanding | $600k | Feb 1, 2024 | $3.1M |
| Jan 30, 2024 | CBAY CymaBay Therapeutics, Inc. | 25,000 0.02% of outstanding | $594k | Jan 30, 2024 | $2.5M |
| Jan 29, 2024 | CBAY CymaBay Therapeutics, Inc. | 50,000 0.04% of outstanding | $1.2M | Jan 29, 2024 | $1.5M |
| Jan 26, 2024 | CBAY CymaBay Therapeutics, Inc. | 20,000 0.02% of outstanding | $461k | Jan 26, 2024 | $1.0M |
| Jan 16, 2024 | CBAY CYMABAY THERAPEUTICS, INC. | 10,000 0.01% of outstanding | $236k | Jan 16, 2024 | $777k |
| Dec 15, 2023 | CYMABAY THERAPEUTICS, INC. | 21,497 0.02% of outstanding | $473k | Dec 15, 2023 | $545k |
| Nov 15, 2023 | CYMABAY THERAPEUTICS, INC. | 17,500 0.02% of outstanding | $304k | Nov 15, 2023 | $520k |
| Oct 16, 2023 | CYMABAY THERAPEUTICS, INC. | 17,500 0.02% of outstanding | $241k | Oct 16, 2023 | $724k |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $4.05 | $41k | 10,000 | Jan 16, 2024 |
| Jan 16, 2024 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $23.58 | $236k | 0 | Jan 16, 2024 |
| Jan 16, 2024 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 135,109 | Jan 16, 2024 |
| Dec 15, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $4.05 | $41k | 10,000 | Dec 15, 2023 |
| Dec 15, 2023 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $21.98 | $220k | 0 | Dec 15, 2023 |
| Dec 15, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +11,497 | $8.43 | $97k | 11,497 | Dec 15, 2023 |
| Dec 15, 2023 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,497 | $21.99 | $253k | 0 | Dec 15, 2023 |
| Dec 15, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 145,109 | Dec 15, 2023 |
| Dec 15, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -11,497 | $0.00 | $0 | 0 | Dec 15, 2023 |
| Nov 15, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +17,500 | $3.45 | $60k | 17,500 | Nov 17, 2023 |
| Nov 15, 2023 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -0 | $17.38 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -17,500 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Oct 16, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +17,500 | $3.45 | $60k | 17,500 | Oct 18, 2023 |
| Oct 16, 2023 | CBAY CymaBay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -0 | $13.76 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | CBAY CymaBay Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -17,500 | $0.00 | $0 | 17,500 | Oct 18, 2023 |
Questions about Daniel Menold
Answered from the filings on this page, as of the latest one.
Is Daniel Menold buying or selling?
Not in the last 12 months. Daniel Menold's latest open-market trade on SEC Form 4 was sold $236k of CBAY on Jan 16, 2024.
How did Daniel Menold's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Menold has 0.
Where does Daniel Menold file Form 4?
Daniel Menold has filed Form 4 at CBAY (CymaBay Therapeutics, Inc.) as Vice President, Finance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.